Impact of Proton Therapy to the Prostate Alone Versus the Whole Pelvis on Patient-reported Outcomes and Toxicities in High-Risk Prostate Cancer Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.1016 ◽

2012 ◽

Vol 84 (3) ◽

pp. S385-S386

Author(s):

L.A. McGee ◽

B.S. Hoppe ◽

R.H. Henderson ◽

C.G. Morris ◽

R.C. Nichols ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Cancer Patients ◽

Proton Therapy ◽

Patient Reported Outcomes ◽

High Risk Prostate Cancer ◽

Patient Reported ◽

Risk Prostate Cancer

Download Full-text

A phase I/II study of acute and late physician assessed and patient-reported morbidity following whole pelvic radiation in high-risk prostate cancer patients

Acta Oncologica ◽

10.1080/0284186x.2021.1979246 ◽

2021 ◽

pp. 1-6

Author(s):

Stine E. Petersen ◽

Lise B. Thorsen ◽

Steinbjørn Hansen ◽

Peter M. Petersen ◽

Henriette Lindberg ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase I ◽

Cancer Patients ◽

Pelvic Radiation ◽

High Risk Prostate Cancer ◽

Patient Reported ◽

Risk Prostate Cancer

Download Full-text

Using Robust Treatment Planning of Intensity Modulated Proton Therapy to Address Rectal Volume Uncertainty in High Risk Prostate Cancer Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.07.1481 ◽

2018 ◽

Vol 102 (3) ◽

pp. e526-e527

Author(s):

A. Brackett ◽

A. Kaiser ◽

Y. Kwok ◽

M. Zhu

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Cancer Patients ◽

Treatment Planning ◽

Proton Therapy ◽

Intensity Modulated Proton Therapy ◽

Intensity Modulated ◽

High Risk Prostate Cancer ◽

Rectal Volume ◽

Risk Prostate Cancer

Download Full-text

Helical Tomotherapy (HT) vs Intensity Modulated Proton Therapy (IMPT) for Whole Pelvis Irradiation in High Risk Prostate Cancer Patients: Planning Comparison and NTCP Analysis

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.07.1613 ◽

2009 ◽

Vol 75 (3) ◽

pp. S708

Author(s):

L. Widesott ◽

A. Pierelli ◽

C. Fiorino ◽

T. Lomax ◽

M. Amichetti ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Cancer Patients ◽

Proton Therapy ◽

Helical Tomotherapy ◽

Intensity Modulated Proton Therapy ◽

Intensity Modulated ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Download Full-text

Patient Reported Outcomes after Hypofractionated Radiotherapy and Long-term Androgen Deprivation for High-risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.07.817 ◽

2010 ◽

Vol 78 (3) ◽

pp. S345

Author(s):

H.C. Quon ◽

D.A. Loblaw ◽

G. Morton ◽

E. Szumacher ◽

C. Danjoux ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Patient Reported Outcomes ◽

Androgen Deprivation ◽

Hypofractionated Radiotherapy ◽

High Risk Prostate Cancer ◽

Patient Reported ◽

Risk Prostate Cancer

Download Full-text

32: Conventional Versus Hypofractionation Radiation for High Risk Prostate Cancer Patients (CHIRP): 24 Months Patient-Reported Quality of Life Outcomes of the Randomized Phase Ii Chirp Trial

Radiotherapy and Oncology ◽

10.1016/s0167-8140(21)08910-6 ◽

2021 ◽

Vol 163 ◽

pp. S16-S17

Author(s):

Fan Yang ◽

Sunita Ghosh ◽

Don Yee ◽

Samir Patel ◽

Matthew Parliament ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

High Risk ◽

Cancer Patients ◽

Life Outcomes ◽

High Risk Prostate Cancer ◽

Randomized Phase Ii ◽

Patient Reported ◽

Risk Prostate Cancer

Download Full-text

Initial patient-reported outcomes of a phase II neoadjuvant apalutamide (ARN-509) and radical prostatectomy in treatment of intermediate to high risk prostate cancer (NEAR) trial

European Urology Supplements ◽

10.1016/s1569-9056(19)31014-0 ◽

2019 ◽

Vol 18 (1) ◽

pp. e1402

Author(s):

X.Y. Yang ◽

E.J. Aslim ◽

K. Chen ◽

T.W. Chong ◽

J.S.P. Yuen ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Phase Ii ◽

Patient Reported Outcomes ◽

High Risk Prostate Cancer ◽

Patient Reported ◽

Risk Prostate Cancer

Download Full-text

Robust Treatment Planning of Intensity Modulated Proton Therapy for Pelvic Lymph Node Irradiation in High-Risk Prostate Cancer Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.06.2400 ◽

2017 ◽

Vol 99 (2) ◽

pp. E748

Author(s):

M. Zhu ◽

A. Kaiser ◽

Y. Kwok ◽

M.V. Mishra ◽

P.P. Amin ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Cancer Patients ◽

Proton Therapy ◽

Intensity Modulated Proton Therapy ◽

Intensity Modulated ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer ◽

Lymph Node Irradiation

Download Full-text

Patient-reported outcomes of neoadjuvant apalutamide (ARN-509) and radical prostatectomy in treatment of intermediate to high risk prostate cancer (NEAR) trial – a phase II trial

European Urology Open Science ◽

10.1016/s2666-1683(20)33701-0 ◽

2020 ◽

Vol 19 ◽

pp. e1649

Author(s):

X.Y. Yang ◽

E.J. Aslim ◽

T.W. Chong ◽

J.S.P. Yuen ◽

K.J. Tay ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Phase Ii ◽

Patient Reported Outcomes ◽

Phase Ii Trial ◽

High Risk Prostate Cancer ◽

Patient Reported ◽

Risk Prostate Cancer

Download Full-text

Association between radiation therapy, surgery, or observation for localized high risk prostate cancer and patient-reported outcomes after 10 years in Asian population

European Urology Supplements ◽

10.1016/s1569-9056(18)30922-9 ◽

2018 ◽

Vol 17 (2) ◽

pp. e102

Author(s):

Q. Shi ◽

X. Liao ◽

Z. Xiaonan ◽

Y. Lu ◽

W. Qiang

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Patient Reported Outcomes ◽

Asian Population ◽

High Risk Prostate Cancer ◽

Patient Reported ◽

Risk Prostate Cancer

Download Full-text

390: Durable Cancer Control in High Risk Prostate Cancer Patients Treated with Radical Prostatectomy

The Journal of Urology ◽

10.1016/s0022-5347(18)30643-8 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 130-130

Author(s):

Markus Graefen ◽

Jochen Walz ◽

Andrea Gallina ◽

Felix K.-H. Chun ◽

Alwyn M. Reuther ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Cancer Patients ◽

Cancer Control ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Download Full-text